XTL Biopharmaceuticals xtlbio.com


XTL Biopharmaceuticals focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.

XTL Biopharmaceuticals focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.

Company (IPO / Went public)

Phone: +972-9-955-7080

Fax:

5 HaCharoshet St.

Ra'anana, 4365603
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
XTL Biopharmaceuticals $44M Sep 27, 2000

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related XTL Biopharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pyrazole compounds Feb 15, 2005 Dec 11, 2012 Patent
4-thio substituted quinoline and naphthyridine compounds Aug 22, 2007 Mar 27, 2012 Patent
3,4-disubstituted coumarin and quinolone compounds Mar 29, 2005 Nov 01, 2011 Patent
Benzofuran compounds May 16, 2005 Aug 09, 2011 Patent
4-ethynyl pyrazole derivative compounds and methods for treatment of hcv Oct 15, 2007 Apr 12, 2011 Patent
See all 7 patents